PHARMACIE STASSEN
ActivePHARMACIE STASSEN has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €127k and a net result of €-123k. Equity is growing by ~2.9% per year across the filed fiscal years. Its solvency ranks better than 27% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
22
/ 100
Critical▼ -10 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0=
Solvency25▼-35
Growth32▼-20
Stability100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.1 against 1.44 in 2024), and 82.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
17.2%
Return on assets
-16.6%
Age of the figures
8 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity fell accordingly. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€123k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 d early
2024
2 d early
2023
23 d early
2022
34 d early
2021
31 d early
2020
37 d early
2019
3 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-123k▼ 39.9%
2024 · €-88k
2018: €14k
2019: €5k
2020: €24k
2021: €22k
2022: €28k
2023: €11k
2024: €-88k
2018 → 2025
Working capital
€41k▼ 69.9%
2024 · €135k
2018: €218k
2019: €221k
2020: €254k
2021: €231k
2022: €275k
2023: €164k
2024: €135k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€300k-€328k▲ 9.4%€339k▲ 3.2%€251k▼ 26.0%€127k▼ 49.2%
Operating result€34k-€45k▲ 32.0%€23k▼ 48.6%€-81k€-112k▼ 39.0%
Net result€22k-€28k▲ 25.9%€11k▼ 62.6%€-88k€-123k▼ 39.9%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €112k in 2025 against €81k in 2024; the loss grows and 2025 is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €736k
Fixed assets
€277k▼ 18.1%
Current assets
€459k▲ 4.1%
Equity and liabilities €742k
Equity
€127k▼ 49.2%
Debt
€615k▲ 14.6%
The debt ratio rises from 68.1% to 82.8%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€-53k▼
2024 · €-26k
Cash flow
€-64k▼
2024 · €-34k
Solvency
17.2%▼
2024 · 31.9%
Current ratio
1.10▼
2024 · 1.44
Quick ratio
0.79▼
2024 · 0.95
Debt / equity
4.82▲
2024 · 2.14
ROE
-96.8%▼
2024 · -35.2%
ROA
-16.6%▼
2024 · -11.2%
Interest coverage
-4.75▼
2024 · -3.07
Debt
€615k▲
2024 · €536k
Debt ≤ 1 year
€418k▲
2024 · €305k
Debt > 1 year
€197k▼
2024 · €231k
Income taxes
€375▼
2024 · €382
Staff costs
€32k▼
2024 · €46k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€787k€742k▼
Formation expenses20€8k€6k▼
Fixed assets21/28€338k€277k▼
Intangible fixed assets21€39k€34k▼
Tangible fixed assets22/27€299k€243k▼
Plant, machinery and equipment23€17k€13k▼
Furniture and vehicles24€14k€6k▼
Leasing and similar rights25€58k€43k▼
Other tangible fixed assets26€210k€181k▼
Financial fixed assets28€124-
Current assets29/58€441k€459k▲
Stocks and contracts in progress3€151k€130k▼
Stocks30/36€151k€130k▼
Amounts receivable within one year40/41€134k€248k▲
Trade receivables40€120k€217k▲
Other amounts receivable41€14k€31k▲
Cash at bank and in hand54/58€156k€82k▼
Equity and liabilities
Total equity and liabilities10/49€787k€742k▼
Equity10/15€251k€127k▼
Contributions10/11€20k€20k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€229k€105k▼
Amounts payable17/49€536k€615k▲
Amounts payable after more than one year17€231k€197k▼
Financial debts170/4€231k€197k▼
Amounts payable within one year42/48€305k€418k▲
Current portion of amounts payable after more than one year42€33k€34k▲
Trade debts44€126k€237k▲
Suppliers440/4€126k€237k▲
Taxes, remuneration and social security45€19k€13k▼
Taxes450/3€10k€3k▼
Remuneration and social security454/9€10k€10k▲
Other amounts payable47/48€127k€134k▲
Income statement
Code20242025
Remuneration, social security and pensions62€46k€32k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€55k€60k▲
Other operating charges640/8€637€5k▲
Gross operating margin9900€20k€-16k▼
Operating profit (loss)9901€-81k€-112k▼
Financial income75/76B€2k€572▼
Recurring financial income75€2k€572▼
Financial charges65/66B€9k€11k▲
Recurring financial charges65€9k€11k▲
Profit (loss) for the period before taxes9903€-88k€-123k▼
Income taxes67/77€382€375▼
Profit (loss) for the period9904€-88k€-123k▼
Profit (loss) for the period to be appropriated9905€-88k€-123k▼
Appropriation of the result
Profit (loss) to be appropriated9906€229k€105k▼
Profit (loss) brought forward from the previous period14P€317k€229k▼
Social balance
Average headcount (FTE)90870.81.0▲
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Weakest financial yearnet €-123k
Net result drops to €-123k, the lowest in the series.
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
27-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Highest result since 2018net €28k ▲25.9%
Operating result €45k, net result €28k, both a record.
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
24-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
03-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 3 days late
2019
30-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
22-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 22 days late
2017
21-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 21 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Pepinster · 1 establishment unit since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Laurent Mairlot 1064860 PepinsterGround area
6,584 m²
Building footprint
573 m²
Volume, LiDAR
2,742 m³
2 parcels, Wallonia · tallest building 10.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Outre-Cour 120, 4651 Herve
since 20012.095.124.972
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 63006D0588/00C002 | Wallonia | 4,339 m² | 1 · 332 m² | 10.4 m · 3 fl. |
| 63083A0318/00E000 | Wallonia | 2,245 m² | 1 · 241 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteHerve2.095.124.972
Similar companies · same sector, comparable size
PHARMACIE FRANÇOISE LAINÉ
BE 0833.930.576
Fontaine-l'Evêque · Eq €127k
PHARMACIE VANNESTE
BE 0806.691.887
Sint-Jans-Molenbeek · Eq €127k
APOTHEEK SINT JACOB
BE 0839.541.037
Antwerpen · Eq €127k
PHARMACIE DE LOUVEIGNE
BE 0887.908.997
Sprimont · Eq €128k
APOTHEEK VAN DER PLAS
BE 0883.632.782
Dilbeek · Eq €128k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,518 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded24-08-2000
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.